Medtronic Reports Three Months Results of DTM Spinal Cord Stimulation Endurance Therapy for the Treatment of Chronic Pain
Shots:
- The company reported the results from an on-label study of DTM spinal cord stimulation endurance therapy in patients with chronic pain. Patients will have additional follow-up assessments after 6 & 12mos.
- The therapy showed an improvement in pain relief as measured by reduction in overall pain on VAS along with a reduction in back & leg pain, 69% of patients improved to a less disabled category as measured by the ODI, 63% showed minimal or moderate disability compared to 16% at baseline @3mos., 75% of patients were satisfied
- The therapy provides additional QoL & functional benefits & allows long-lasting recharge-free performance on Vanta and 5 min. recharge on Intellis neurostimulators
Ref: Medtronic | Image: Medtronic
Click here to read the full press release
Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on connect@pharmashots.com
